About PSM
Prescription Drug Freight Fraud Report, June 2025
What if your tirzepatide shipment came from a Brazilian beauty clinic? Or a vial of semaglutide was manufactured, supposedly, at a Costco in Toronto? In April and May 2025, dozens of shipments of semaglutide, tirzepatide, apixaban, and antibiotics entered the U.S. from facilities that aren’t in the FDA’s drug manufacturing database. These aren’t low-volume personal-use…
[...]Partnership for Safe Medicines Applauds Reintroduction of the Cooper Davis Devin Norring Act
The Partnership for Safe Medicines (PSM) today announced its strong support for the reintroduction of the Cooper Davis Devin Norring Act, a bipartisan effort aimed at curbing the online sale of deadly counterfeit and illicit drugs.
[...]Pill press update: January through June 2025
Pill presses and molds are used to make fake pills with deadly consequences thousands of people every year. The number of Americans that take fake pills annually without a fatal event is even higher. Read our January through June 2025 report covering pill press seizures, policy developments, and legislation.
[...]The End of GLP-1 Compounding
Federally-registered compounding facilities stopped making tirzepatide on May 22. This transition is significant for patients, and we at PSM think there are four things you should be watching for.
[...]Empower Pharmacy’s no good, very bad week
Articles in Endpoints News and the Houston Chronicle raise questions about the regulatory process for 503B compounding facilities.
[...]Prescription Drug Freight Fraud Report, May 2025
What if your blood thinners were made in an unverified location in Colombia? In March 2025, dozens of pharmaceutical shipments entered the U.S. that were manufactured in places no one would expect.
[...]New initiative: Best practices for online pharmacy-to-pharmacy marketplaces
PSM is seeking input on developing a set of best practices to reduce sales of counterfeit and diverted medicines on online pharmacy-to-pharmacy marketplaces.
[...]Handout: Illegal ingredients linked to knockoff weight loss drugs pouring in from foreign sources
Compounded versions of GLP-1 injectable treatments for diabetes and obesity have surged in popularity despite a lack the safety and efficacy assurances. The FDA has warned that these knockoff versions sometimes contain illicit semaglutide or tirzepatide—the active pharmaceutical ingredients (APIs) in weight loss drugs. Working with George Karavetsos, former director of FDA’s Office of Criminal…
[...]PSM submits comment on CBP’s proposed rules to improve screening of low-value shipments
On March 14, the Partnership for Safe Medicines submitted comment on Customs and Border Protection’s proposed update to regulations around low-value, “de minimus” shipments.
[...]Prescription Drug Affordability Boards by the numbers
Prescription Drug Affordability Boards are an expensive idea that has not produced results. It’s time to move on.
[...]